Use of intravenous esmolol to predict efficacy of oral beta-adrenergic blocker therapy in patients with neurocardiogenic syncope
- 29 February 1992
- journal article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 19 (2), 402-408
- https://doi.org/10.1016/0735-1097(92)90498-c
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Echocardiographic demonstration of decreased left ventricular dimensions and vigorous myocardial contraction during syncope induced by head-up tiltJournal of the American College of Cardiology, 1991
- Sequential catecholamine changes during upright tilt: Possible hormonal mechanisms responsible for pathogenesis of neurocardiogenic syncopeJournal of the American College of Cardiology, 1991
- TILTING TOWARDS A DIAGNOSIS IN RECURRENT UNEXPLAINED SYNCOPEThe Lancet, 1989
- Provocation of Bradycardia and Hypotension by Isoproterenol and Upright Posture in Patients with Unexplained SyncopeThe New England Journal of Medicine, 1989
- Isoproterenol induction of vasodepressor-type reaction in vasodepressor-prone personsThe American Journal of Cardiology, 1989
- Esmolol: A titratable short-acting intravenous beta blocker for acute critical care settingsAmerican Heart Journal, 1987
- Role of cardiac vagal c-fibers in cardiovascular controlPublished by Springer Science and Business Media LLC ,1979
- Reflex control of the peripheral circulationProgress in Cardiovascular Diseases, 1976
- The Regulation of the Blood Distribution in ManActa Physiologica Scandinavica, 1952
- Depressor Reflexes from the HeartActa Physiologica Scandinavica, 1948